Ken Griffin's position in Genmab is currently worth $91.5 Million. That's 0.09% of their equity portfolio (286th largest holding). The first Genmab trade was made in Q3 2019. Since then Ken Griffin bought shares 35 more times and sold shares on 22 occasions. The investor's estimated purchase price is $109 Million, resulting in a loss of 16%.